Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study

OBJECTIVE: This study aims to evaluate the change in serum metalloproteinase-3 (MMP-3) following the management of active rheumatoid arthritis (RA) and define the relationships between MMP-3 and disease activity indices. METHODS: Data from a previously reported a 24-week, randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Jina, Baek, Han Joo, Song, Yeong Wook, Lee, Eun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351360/
https://www.ncbi.nlm.nih.gov/pubmed/37475900
http://dx.doi.org/10.4078/jrd.2022.29.2.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351360/
https://www.ncbi.nlm.nih.gov/pubmed/37475900
http://dx.doi.org/10.4078/jrd.2022.29.2.89

Ejemplares similares